Brief: Flame Study Demonstrates 90% Survival Improvement In High-Risk Pulmonary Embolism With Inari Medical Flowtriever System
06/03/2023 13:05
March 6 (Reuters) - Inari Medical Inc NARI.O :
* FLAME STUDY DEMONSTRATES 90% SURVIVAL IMPROVEMENT IN
HIGH-RISK
PULMONARY EMBOLISM WITH INARI MEDICAL FLOWTRIEVER SYSTEM
Source text for Eikon: ID:nGNXS6j4Z
Further company coverage: NARI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty